Masimo Corporation is a medical technology company which develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring. It also provides a platform that noninvasively monitors hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate and other parametres. In addition, the Company offers SedLine brain function monitoring technology to measure the brain's electrical activity, capnography and gas monitoring products. Further, it provides surveillance, remote monitoring, and clinician notification solutions, a wireless presence-detection system and connectivity devices.

Irvine, US
Size (employees)
1,243 (est)
Masimo Corporation was founded in 1989 and is headquartered in Irvine, US
Report incorrect company information

Key People/Management at Masimo Corporation

Joe Kiani

Joe Kiani

Chief Executive Officer & Chairman of the Board
Anand Sampath

Anand Sampath

Chief Operating Officer
Micah Young

Micah Young

Executive Vice President & Chief Financial Officer
Jon Coleman

Jon Coleman

President, Worldwide Sales & Professional Services and Medical Affairs
Yongsam Lee

Yongsam Lee

Executive Vice President & Chief Information Officer
Tom McClenahan

Tom McClenahan

Executive Vice President, General Counsel

Masimo Corporation Office Locations

Masimo Corporation has offices in Danderyd, Tres Cantos, Tilburg, Milano and in 47 other locations
Irvine, US (HQ)
52 Discovery
Frenchs Forest, AU
Suite 3, Building 7 49 Frenchs Forest Rd Frenchs Forest
Wien, AT
18 Meldemannstraße
Saint-Laurent, CA
4878 Rue Levy Street, Suite 200
Beijing, CN
#1004, Hopson Building 13 Deshengmen Wai Street Xicheng District
Ecully, FR
Espace Europeen Ecully 15 Chemin du Saquin, Bat G
Show all (52)
Report incorrect company information

Masimo Corporation Financials and Metrics

Masimo Corporation Financials

Masimo Corporation's revenue was reported to be $663.85 m in FY, 2016 which is a 5.4% increase from the previous period.

Revenue (Q2, 2017)

192.9 m

Gross profit (Q2, 2017)

128.4 m

Gross profit margin (Q2, 2017), %


EBIT (Q2, 2017)

46.9 m

Market capitalization (25-Apr-2018)

5 b

Cash (30-Dec-2017)

315.3 m
Masimo Corporation's current market capitalization is $5 b.
USDFY, 2015FY, 2016


630.1 m663.8 m

Revenue growth, %


General and administrative expense

252.7 m241 m

Operating expense total

252.7 m241 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017


131.4 m139.8 m140.9 m144.1 m152.6 m154.5 m167.6 m171.2 m172.6 m186.3 m192.9 m

Cost of goods sold

44 m47.5 m47.8 m47.9 m50.3 m51.4 m57.5 m57 m57.5 m62.2 m64.5 m

Gross profit

87.5 m92.3 m93.1 m96.2 m102.2 m103.1 m110.1 m114.2 m115.1 m124.1 m128.4 m

Gross profit Margin, %

USDFY, 2015FY, 2016FY, 2017


132.3 m306 m315.3 m


62 m72.5 m95.9 m

Current Assets

299.1 m507.2 m564.1 m


132.5 m136 m164.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017


91.7 m117.5 m97.1 m119 m103.6 m135.7 m119.4 m126 m139.9 m116.1 m343.8 m331.4 m


59.5 m55.5 m58.3 m62.8 m73.3 m69.6 m71.6 m67 m62.5 m62.3 m80.3 m88.5 m

Current Assets

261.9 m286.7 m272 m299.6 m297.5 m315.5 m309.6 m324.6 m317.5 m296 m556.3 m566 m


24.9 m25.5 m82.4 m87.6 m128.6 m108.7 m122.7 m133.2 m133.3 m133 m136.2 m137.7 m
USDFY, 2015FY, 2016FY, 2017

Net Income

81.5 m300.7 m131.6 m

Depreciation and Amortization

15.7 m16.8 m20.1 m

Accounts Payable

(4.3 m)7.8 m(4.1 m)

Cash From Operating Activities

114.2 m416.8 m56.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017

Net Income

15.5 m22.5 m14 m16.1 m19.8 m


58.3 m62.8 m73.3 m69.6 m71.6 m67 m62.5 m62.3 m80.3 m

Accounts Payable

29.1 m29 m28.7 m27.1 m32.5 m32.2 m25.3 m30.7 m35 m
USDY, 2017


155.2 k

Financial Leverage

1.3 x
Show all financial metrics

Masimo Corporation Operating Metrics

FY, 2016

Patents Issued


Patents Pending

Show all operating metrics
Report incorrect company information